Holen Sie sich die Stockscreener-App
172.41
2.53%
-4.48
Handel nachbörslich:
173.00
0.59
+0.34%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BDX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Becton Dickinson Co Aktie (BDX) Neueste Nachrichten
Becton, Dickinson and Company Submits Application to the FDA for a New, At-Home HPV Test - Insider Monkey
First Eagle Investment's Strategic Moves: Spotlight on Becton Dickinson & Co - Yahoo Finance
Stock Analysis | Becton, Dickinson OutlookA Cautious Call Amid Mixed Technical and Analyst Signals - AInvest
BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories – Company AnnouncementFT.com - Financial Times
BD to invest $35M to expand Nebraska syringe manufacturing - MassDevice
BD invests $35M to expand syringe plant in Nebraska - NJBIZ
BD to Invest $35 Million in Nebraska Facility - citybiz
$35M Investment: BD Boosts Critical US Medical Supply Chain with Major Nebraska Factory Expansion - Stock Titan
Covington resident wins $20 million in case against Becton Dickinson - The Covington News
Becton Dickinson Stock Dives 1.81% Amid 100.16% Volume Spike to $670M Ranking 199th in Market Activity as FDA Submission Drives Volatility - AInvest
Earnings Preview: Becton Dickinson (BDX) Q3 Earnings Expected to Decline - Yahoo Finance
BD receives FDA clearance for rapid point-of-care COVID-19 test By Investing.com - Investing.com South Africa
BD receives FDA clearance for rapid point-of-care COVID-19 test - Investing.com
Becton Dickinson receives FDA clearance for BD Veritor System for SARS-CoV-2 - TipRanks
BD's New FDA-Cleared COVID Test Delivers Results in Just 15 Minutes: What Healthcare Providers Should Know - Stock Titan
Former Masimo COO Bilal Muhsin Joins BD - Orange County Business Journal
Is Becton Dickinson and Company stock overvalued or undervaluedBuild wealth faster with high-performing stocks - jammulinksnews.com
What are analysts’ price targets for Becton Dickinson and Company in the next 12 monthsAchieve breakthrough financial growth - jammulinksnews.com
Becton Dickinson, BNY, Incyte, Duolingo, Jabil: Major Stock Sales Unveiled! - TipRanks
Earnings Preview: What To Expect From Becton, Dickinson And Company's Report - Barchart.com
Becton, Dickinson and Co’s PUREST Study: A New Era in Urine Management - TipRanks
Becton Dickinson Surges to 247th in Trading Volume with $477 Million in Shares Traded - AInvest
Becton, Dickinson and Company (BDX) Fell in Q2 as Earnings Fell Short of Expectations - Insider Monkey
What drives Becton Dickinson and Company stock priceBreakthrough financial growth - Jammu Links News
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs - Quantisnow
Is Becton Dickinson and Company a good long term investmentBreakthrough financial growth - jammulinksnews.com
Becton Dickinson & Co To Go Ex-Dividend On September 8th, 2025 With 1.04 USD Dividend Per Share - 富途牛牛
Becton Dickinson Investors Seek Final OK Of $9M Deal - Law360
Top Executive Sells Over a Thousand Shares of Becton Dickinson Stock! - TipRanks
Becton Dickinson & Co Slips to 346th in Trading Volume Despite 3.39% Stock Price Gain - AInvest
BD Shareholders to Receive $4.16 Annual Dividend: Next Quarterly Payment Details Revealed - Stock Titan
Jim Cramer Notes Becton Dickinson Stock Recently “Finished in the Black” - MSN
Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal - MSN
The Smartest Dividend Stock to Buy With $1,000 Right Now - The Motley Fool
Vascular Access Devices Company Evaluation Report 2025 | Becton Dickinson, Teleflex, and ICU Medical Strengthen Global Leadership Through Strategic Acquisitions and Product Innovation - Yahoo Finance
Becton Dickinson’s SWOT analysis: merger, spin-off reshape med tech stock - Investing.com
BD issues voluntary recall on certain Alaris infusion pump modules - MassDevice
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Announces Target Price $190 - 富途牛牛
Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX) - 富途牛牛
Morgan Stanley Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $196 - 富途牛牛
BD issues update to recall of Alaris & BD Alaris pump modules - MarketScreener
BD to spin off biosciences, diagnostics businesses in $17.5B deal (updated) - NJBIZ
Waters to acquire BD flow cytometry business in a deal valued at $17.5 billion - C&EN
Becton Dickinson and : BD Issues Update to Voluntary Global Recall of Alaris™ and BD Alaris™ Pump Modules Serviced with Legacy Bezel Kit Assemblies - MarketScreener
How Do Investors Really Feel About Becton Dickinson? - 富途牛牛
Becton Dickinson stock holds steady as TD Cowen maintains $183 price target By Investing.com - Investing.com South Africa
Becton Dickinson stock holds steady as TD Cowen maintains $183 price target - Investing.com Nigeria
Becton, Dickinson & Co (BDX) Is Paying a $85M Settlement to Investors — Here’s How to Get Your Share - TradingView
Becton, Dickinson and Company (BDX) Traded Down on Weak Earnings - Insider Monkey
Becton, Dickinson and Company: A Solid Divestment For Its Bioscience And Diagnostics Business - Seeking Alpha
Becton Dickinson’s Hold Rating Amid Strategic Moves and Limited Immediate Upside - TipRanks
TD Cowen Initiates Becton Dickinson & Co(BDX.US) With Hold Rating, Announces Target Price $183 - 富途牛牛
Waters, BD’s Biosciences & Diagnostic Solutions to combine - Medical Buyer
A Big Move By Waters Corporation And Becton, Dickinson And Company (NYSE:WAT) - Seeking Alpha
William Blair Maintains Becton Dickinson & Co(BDX.US) With Hold Rating - 富途牛牛
1.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):